Examining the prostate cancer diagnostic pathway and the risk analysis. As we move to a novel MRI and targeted biopsy approach for diagnostics, this ReIMAGINE study asseses the risks involved in a new diagnostic approach and the need to adjust risk pathways to adapt to these new techniques.